What is the recommended treatment for Chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Chlamydia

The first-line treatment for uncomplicated chlamydial infections is doxycycline 100 mg orally twice daily for 7 days, which is highly effective and preferred over alternatives due to its superior efficacy and lower cost. 1

First-Line Treatment Options

  • Doxycycline: 100 mg orally twice daily for 7 days

    • High efficacy rate (>99% for rectal infections) 2
    • Lower cost compared to alternatives 1
    • Contraindicated in pregnancy and children under 8 years 1
  • Azithromycin: 1 g orally in a single dose

    • Advantage of single-dose administration improving compliance 1
    • Particularly useful when compliance with multi-day regimens cannot be ensured 3
    • Efficacy approximately 83% for rectal infections (lower than doxycycline) 2
    • Not recommended during pregnancy 3

Alternative Treatment Options

For patients who cannot tolerate first-line treatments:

  • Ofloxacin: 300 mg orally twice daily for 7 days 1

    • Contraindicated in pregnancy and patients ≤17 years 1
  • Levofloxacin: 500 mg orally once daily for 7 days 1

    • Contraindicated in pregnancy and patients ≤17 years 1
  • Erythromycin: 500 mg orally four times daily for 7 days 3, 1, 4

    • Alternative for those who cannot tolerate other regimens
    • Higher incidence of gastrointestinal side effects
    • Erythromycin estolate is contraindicated during pregnancy due to hepatotoxicity 3

Special Populations

Pregnant Patients

  • Azithromycin: 1 g orally in a single dose (first choice) 1
  • Amoxicillin: 500 mg orally three times daily for 7-10 days (alternative) 3, 1
  • Erythromycin base: 500 mg orally four times daily for 7 days 3
    • If not tolerated: 250 mg orally four times daily for 14 days 3

Children

  • Children >45 kg but <8 years: Azithromycin 1 g orally in a single dose 1
  • Children >8 years: Azithromycin 1 g orally in a single dose OR Doxycycline 100 mg orally twice daily for 7 days 1
  • Children <45 kg: Erythromycin 50 mg/kg/day orally divided into four doses for 14 days 1

Follow-Up and Partner Management

  • Routine test-of-cure is not recommended after treatment with doxycycline or azithromycin unless symptoms persist 1
  • If test-of-cure is performed, it should be done 3-4 weeks after treatment completion 1
  • Patients should be rescreened 3-4 months after treatment due to high risk of reinfection 1
  • All sexual partners from the previous 60 days should be evaluated, tested, and treated 1
  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of multi-day regimen 1

Important Clinical Considerations

  • Test for other STIs, especially gonorrhea, which commonly co-occurs with chlamydial infections 1
  • Consider testing for syphilis and HIV 1
  • Medications should ideally be dispensed on-site with the first dose directly observed 1
  • Single-dose azithromycin has traditionally been used to ensure compliance, with 100% compliance when directly observed 1, 5

Common Pitfalls to Avoid

  1. Inadequate partner treatment: A major cause of reinfection; ensure all sexual partners are treated 1
  2. Testing too soon after treatment: Can lead to false-positive results; wait 3-4 weeks if test-of-cure is needed 1
  3. Inappropriate treatment for rectal chlamydia: Doxycycline is significantly more effective than azithromycin for rectal infections (99.6% vs 82.9% efficacy) 2
  4. Overlooking drug interactions: Be aware of potential interactions between azithromycin/erythromycin and other medications, particularly those metabolized by CYP3A4 1

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.